Prais Dario, Amir Jacob, Nussinovitch Moshe
Department of Pediatrics C, Schneider Children's Medical Center of Israel, Petah Tiqva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
J Clin Rheumatol. 2007 Feb;13(1):25-8. doi: 10.1097/01.rhu.0000255692.46165.19.
Henoch-Schönlein purpura (HSP), also known as anaphylactoid purpura is a clinically recognizable systemic disorder occurring in children, mainly from ages 3 to 10 years.
To describe the clinical, epidemiological, and laboratory findings in a group of patients with recurrent HSP, admitted to a tertiary pediatric center.
Retrospective analysis of medical records of patients hospitalized due to HSP between 1969 and 2004.
Two hundred sixty children (56.7% males) were hospitalized due to HSP, 7 (2.7%) more than once. There were no statistically significant differences in demographic or clinical characteristics between the patients with 1 event of HSP and patients with recurrence. Mean age of the subgroup with recurrence was 3.67 years (10 months to 7.4 years) at the first episode, and 5.03 years (2.2-10 years) at the second one, with a mean lag period of 13.5 +/- 2.8 months (range 2-26). The duration of the recurrent clinical symptoms ranged from 9 to 30 days, and in 72% of those patients, resolution took more than 14 days.
In our inpatient population, no clinical or laboratory characteristics were found to be predictive of recurrence; the second episode was longer than the first and the lag period between the 2 episodes was substantially longer than previously reported. Hospital admissions for recurrent HSP are not common. Nevertheless, a good prognosis was the rule of our admitted patients.
过敏性紫癜(HSP),也称为类过敏性紫癜,是一种临床上可识别的系统性疾病,主要发生在3至10岁的儿童中。
描述一组入住三级儿科中心的复发性HSP患者的临床、流行病学和实验室检查结果。
对1969年至2004年间因HSP住院的患者病历进行回顾性分析。
260名儿童(56.7%为男性)因HSP住院,其中7名(2.7%)复发。HSP发作一次的患者与复发患者在人口统计学或临床特征方面无统计学显著差异。复发亚组首次发作时的平均年龄为3.67岁(10个月至7.4岁),第二次发作时为5.03岁(2.2 - 10岁),平均间隔期为13.5 +/- 2.8个月(范围2 - 26个月)。复发性临床症状持续时间为9至30天,其中72%的患者症状缓解时间超过14天。
在我们的住院患者中,未发现临床或实验室特征可预测复发;第二次发作比第一次长,两次发作之间的间隔期比先前报道的长得多。复发性HSP的住院情况并不常见。然而,我们收治的患者预后良好。